The NM_003494.4: c.3805dup p.(Glu1269GlyfsTer7) variant in DYSF, which is also known as NM_001130987.2: c.3859dup p.(Glu1287GlyfsTer7), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 34/55, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been detected in at least two individuals with features of LGMD, including in unknown phase with a pathogenic variant (NM_003494.4: c.5698_5699del p.(Ser1900GlnfsTer14), 0.5 pts, PMID: 27602406; 36983702; PM3_Supporting). At least one patient with this variant and a second presumed diagnostic variant in DYSF displayed a clinical suspicion of LGMD or progressive limb girdle muscle weakness and severely reduced or absent dysferlin protein expression, which is highly specific for DYSF-associated LGMD (PP4_Strong, PMID: 27602406; 36983702). The filtering allele frequency of this variant is 0.000020771 in gnomAD v4.1.0 exomes (the upper threshold of the 95% CI of 15/1112008 European (non-Finnish) chromosomes), which is less than the ClinGen LGMD VCEP threshold (≤0.0001) (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 04/11/2025): PVS1, PM3_Supporting, PP4_Strong, PM2_Supporting.